BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salazar-Camarena DC, Ortíz-Lazareno P, Marín-Rosales M, Cruz A, Muñoz-Valle F, Tapia-Llanos R, Orozco-Barocio G, Machado-Contreras R, Palafox-Sánchez CA. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus. Cytokine 2019;114:115-27. [PMID: 30467093 DOI: 10.1016/j.cyto.2018.11.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Tenbrock K, Rauen T. T cell dysregulation in SLE. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109031] [Reference Citation Analysis]
2 Baker D, Pryce G, James LK, Schmierer K, Giovannoni G. Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis. Eur J Neurol 2019;27:221-8. [DOI: 10.1111/ene.14105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
3 Zhang Y, Tian J, Xiao F, Zheng L, Zhu X, Wu L, Zhao C, Wang S, Rui K, Zou H, Lu L. B cell-activating factor and its targeted therapy in autoimmune diseases. Cytokine & Growth Factor Reviews 2021. [DOI: 10.1016/j.cytogfr.2021.11.004] [Reference Citation Analysis]
4 Drumond MHF, Puhl LE, Duarte PM, Miranda TS, Clemente-Napimoga JT, Peruzzo DC, Martinez EF, Napimoga MH. Preliminary findings on the possible role of B-lymphocyte stimulator (BLyS) on diabetes-related periodontitis. Braz Oral Res 2020;34:e038. [PMID: 32374812 DOI: 10.1590/1807-3107bor-2020.vol34.0038] [Reference Citation Analysis]
5 Arévalo B, Blázquez-garcía M, Valverde A, Serafín V, Montero-calle A, Solís-fernández G, Barderas R, Yáñez-sedeño P, Campuzano S, Pingarrón J. Simultaneous electrochemical immunosensing of relevant cytokines to diagnose and track cancer and autoimmune diseases. Bioelectrochemistry 2022. [DOI: 10.1016/j.bioelechem.2022.108157] [Reference Citation Analysis]
6 Liu L, Akkoyunlu M. Circulating CD138 enhances disease progression by augmenting autoreactive antibody production in a mouse model of systemic lupus erythematosus. J Biol Chem 2021;297:101053. [PMID: 34364875 DOI: 10.1016/j.jbc.2021.101053] [Reference Citation Analysis]
7 Chen Y, Yang M, Long D, Li Q, Zhao M, Wu H, Lu Q. Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients. Autoimmunity 2020;53:192-200. [PMID: 32157911 DOI: 10.1080/08916934.2020.1736049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Xu WD, Su LC, Liu XY, Wang JM, Yuan ZC, Qin Z, Zhou XP, Huang AF. IL-38: A novel cytokine in systemic lupus erythematosus pathogenesis. J Cell Mol Med 2020;24:12379-89. [PMID: 33079487 DOI: 10.1111/jcmm.15737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Colasanti T, Spinelli FR, Barbati C, Ceccarelli F, Scarpa S, Vomero M, Alessandri C, Valesini G, Conti F. Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus. Cells 2022;11:262. [DOI: 10.3390/cells11020262] [Reference Citation Analysis]
10 Degner KR, Wilson NA, Reese SR, Parajuli S, Aziz F, Garg N, Mohamed M, Singh T, Mandelbrot DA, Panzer SE, Redfield RR, Van Hyfte K, Zhong W, Hidalgo LG, Djamali A. Short-Term Immunopathological Changes Associated with Pulse Steroids/IVIG/Rituximab Therapy in Late Kidney Allograft Antibody Mediated Rejection. Kidney360 2020;1:389-98. [DOI: 10.34067/kid.0001082019] [Reference Citation Analysis]
11 Degner KR, Wilson NA, Reese SR, Parajuli S, Aziz F, Garg N, Mohamed M, Singh T, Mandelbrot DA, Panzer SE, Redfield RR, Van Hyfte K, Zhong W, Hidalgo LG, Djamali A. Short-term Immunopathological Changes Associated with Pulse Steroids/IVIG/Rituximab Therapy in Late Kidney Allograft Antibody Mediated Rejection. Kidney360 2020;1:389-98. [PMID: 34476406 DOI: 10.34067/kid.0001082019] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li G, Zhang Q, Liu Z, Shen H, Zhu Y, Zhou Z, Ding W, Han S, Zhou J, Ou R, Luo M, Liu S. TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss. Cancer Cell Int 2021;21:223. [PMID: 33865370 DOI: 10.1186/s12935-021-01923-x] [Reference Citation Analysis]
13 Tan W, Gu Z, Leng J, Zou X, Chen H, Min F, zhou W, Zhang L, Li G. Let-7f-5p ameliorates inflammation by targeting NLRP3 in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Biomedicine & Pharmacotherapy 2019;118:109313. [DOI: 10.1016/j.biopha.2019.109313] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
14 Hong S, Park KH, Lee YE, Shin S, Kim HJ, Kim YM. Antibody microarray analysis of the amniotic fluid proteome for predicting the outcome of rescue cerclage in patients with cervical insufficiency. Biosci Rep 2021;41:BSR20210174. [PMID: 34195783 DOI: 10.1042/BSR20210174] [Reference Citation Analysis]
15 Yin R, Xu R, Ding L, Sui W, Niu M, Wang M, Xu L, Wang H, Srirat C. Circulating IL-17 Level Is Positively Associated with Disease Activity in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Biomed Res Int 2021;2021:9952463. [PMID: 34337065 DOI: 10.1155/2021/9952463] [Reference Citation Analysis]